Tina Kennedy Type 1 Diabetes, Diagnosed 2001 Endocrinologist: Dr. Hani Alasaad Certified Diabetes Educator: Melissa Finley, RD Location: LMC Barrie When Tina was first diagnosed with type 1 diabetes at the age of 21 she was unsure of what this meant for her future. In elementary school, she had a classmate whose type 1 diabetes was […]
On October 6 – 8th 2017, LMC|Manna Research’s Management Team was represented at the Society of Clinical Research Sites (SCRS) annual Global Solutions Summit Conference in Boca Raton, Florida. The SPRIA award recognizes a research site that has developed and implemented an innovative patient recruitment program. This year, three finalists were chosen by an independent […]
LMC | Manna Research’s own Lydia Frost, Regional Site Lead – Research, won the 2017 Clinical Research Coordinator of the Year – The Americas Award, presented by PharmaTimes Media Ltd. This year’s competition was held in association with the ACRP 2017 Meeting & Expo, the leading education and networking event for clinical research professionals. Designed to recognize and […]
Our dapa real-world evidence manuscript has now been published in Diabetes Technology & Therapeutics! Read the full manuscript here: Dapagliflozin Real-World Evidence (Diabetes Technology & Therapeutics)
Recently published in Diabetes, Obesity and Metabolism – Our simple observational study shows the importance of fixed dose combinations and reduced pill burden in type 2 diabetes! Read the full article here: Glycemic Improvement with a Fixed-dose combination of DPP-4 inhibitor + metformin in patients with Type 2 diabetes (GIFT study)
Vaccines are not just for children – all adults need vaccines to protect their health against common diseases that can be serious. Every year, tens of thousands of adults die from diseases that could have been prevented by vaccines. Other then getting your flu shot every year, there are three things that determine which other […]
Continuous glucose monitoring (CGM) is often considered a technology for insulin pump users – not those on injections. New results from Dexcom’s DIaMonD study, presented at the ADA Scientific Sessions, will hopefully change that. DIaMonD examined if the addition of CGM in those on multiple daily injections (MDI) could help improve blood sugar control. In […]
Great news in the world of vaccines! In the ZOE-70 Study, the herpes zoster subunit vaccine (HZ/su) was showed to decrease the risk of herpes zoster by 89.8% in adults 70 years of age and older. Herpes zoster, or shingles, results from the reactivation of latent varicella–zoster virus (VZV) and is recognized as a painful […]
GlaxoSmithKline’s experimental vaccine to prevent the intensely painful condition known as shingles remained 90 percent effective in people over age 70 even four years after receiving the injection, according to data published on Wednesday. In clinical trials, GSK’s Shingrix has shown greater protection for older recipients than what has been demonstrated by Merck & Co’s […]
Diabetes player Senseonics unveiled topline results from a clinical investigation of its long-term continuous glucose monitoring implant, indicating “significant” accuracy. The Senseonics System consists of a subcutaneously implanted sensor, a transmitter patch worn on the skin over the implant, and a mobile device. The implant, a fluorescent polymer surrounded by a biocompatible material, is intended […]